BOT
Click for more information
0.00% 36.0¢ botanix pharmaceuticals ltd

Ann: Update on BTX 1801 Phase 2a Clinical Study, page-39

  1. justin_2688
    141 Posts.
    lightbulb Created with Sketch. 17
    clock Created with Sketch.
    14/12/20
    11:30
    Post #: 49556324
    So does the study remain double blind until results are tabled or does the company become aware of majority of results as the study is completed?
    BOT Price at posting: 13.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
MCT Metalicity looking for offers on Admiral Bay zinc project
right-arrow Created with Sketch.
AGY Argosy signs deal to sell battery-grade Rincon lithium to Korea
right-arrow Created with Sketch.
NRX Noronex joins forces with South32 to look for copper in Namibia
right-arrow Created with Sketch.
ABY Adore Beauty FY24 revenues up 7.4% YoY to $196M
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
36.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $642.5M
Open High Low Value Volume
36.5¢ 37.0¢ 35.0¢ $1.370M 3.812M

Buyers (Bids)

No. Vol. Price($)
15 316602 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 230398 5
View Market Depth
Last trade - 15.07pm 23/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.